Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | ABVX | TECH | ||
| Company | Biomarin Pharmaceuticals | Abivax Sa ADR | Bio-Techne Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.52 | 138.87 | 70.90 | ||
| High | 59.43 | 146.68 | 71.00 | ||
| Low | 58.10 | 137.63 | 70.65 | ||
| Latest | 58.99 | 144.65 | 70.83 | ||
| Change | +1.17 | +12.09 | -0.17 | ||
| % Change | +2.02% | +9.12% | -0.24% | ||
| Volume | 1,483,500 | 4,015,700 | 7,826,200 | ||
| 20-Day Average Volume | 2,081,160 | 2,829,815 | 7,876,540 | ||
| Previous Close | 57.82 | 132.56 | 71.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 56.68 | 104.52 | 59.69 | ||
| 20-Day Raw Stochastic | 85.84% | 97.18% | 98.00% | ||
| 20-Day Relative Strength | 58.99 | 64.76 | 71.63 | ||
| Weighted Alpha | +5.06 | +113.25 | +35.36 | ||
| Today's Opinion | 56% Buy | 24% Buy | 40% Buy | ||
| Previous Opinion | 56% Buy | 8% Buy | 40% Buy | ||
| Last Month's Opinion | 64% Sell | 16% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.86% since 06/25/26 | +56.60% since 06/25/26 | +0.18% since 06/25/26 | ||
| Low | 56.43 on 06/30/26 | 93.01 on 06/26/26 | 70.55 on 06/30/26 | ||
| High | 59.77 on 06/26/26 | 146.68 on 07/02/26 | 71.23 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +10.63% since 06/02/26 | +99.52% since 06/02/26 | +42.31% since 06/02/26 | ||
| Low | 53.01 on 06/03/26 | 74.79 on 06/24/26 | 49.04 on 06/03/26 | ||
| High | 59.77 on 06/26/26 | 146.68 on 07/02/26 | 71.23 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +6.29% since 04/02/26 | +22.20% since 04/02/26 | +33.31% since 04/02/26 | ||
| Low | 49.26 on 05/18/26 | 69.81 on 06/02/26 | 43.19 on 05/15/26 | ||
| High | 59.77 on 06/26/26 | 146.68 on 07/02/26 | 71.23 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | -0.77% since 01/02/26 | +8.13% since 01/02/26 | +18.74% since 01/02/26 | ||
| Low | 49.26 on 05/18/26 | 69.81 on 06/02/26 | 43.19 on 05/15/26 | ||
| High | 66.28 on 02/24/26 | 146.68 on 07/02/26 | 72.16 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,401,824 | 11,538,729 | 11,089,782 | ||
| Shares Outstanding, K | 193,284 | 79,770 | 156,569 | ||
| Annual Sales | 3,221,250,000 | 0 | 1,219,640,000 | ||
| Annual Net Income | 348,900,000 | -380,270,000 | 73,400,000 | ||
| Last Quarter Sales | 766,210,000 | 0 | 311,420,000 | ||
| Last Quarter Net Income | 105,530,000 | -56,730,000 | 51,050,000 | ||
| 60-Month Beta | 0.24 | 0.87 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 05/04/26 | -0.71 on 05/22/26 | 0.53 on 05/06/26 | ||
| Earnings Date | 08/03/26 | 09/14/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 05/18/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/18/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 28.48 | 0.00 | 40.80 | ||